Different results for two amyloid-clearing antibody drugs reinforce need to advance robust, diverse pipeline for Alzheimer's disease SAN FRANCISCO, Nov. 30, 2022 /PRNewswire/ -- The phase 3 trial results for lecanemab and gantenerumab presented at the Clinical Trials on Alzheimer's...
News Ticker
- [ March 30, 2023 ] Scientist, Strain Engineering – Willow Biosciences – Mountain View, CA San Francisco Biotech Jobs
- [ March 30, 2023 ] Laboratory Technician – Willow Biosciences – Mountain View, CA San Francisco Biotech Jobs
- [ March 30, 2023 ] Scientist, Computational Biology – Willow Biosciences – Mountain View, CA San Francisco Biotech Jobs
- [ March 30, 2023 ] Associate Scientist, Fermentation – Willow Biosciences – Mountain View, CA San Francisco Biotech Jobs
- [ March 30, 2023 ] Associate Scientist, Chemistry – Willow Biosciences – Mountain View, CA San Francisco Biotech Jobs
Copyright © 2022 Biotech Networks, LLC
